Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leiomyoma | 10 | 2019 | 636 | 2.800 |
Why?
|
| Fertilization in Vitro | 20 | 2019 | 1292 | 2.700 |
Why?
|
| Infertility | 6 | 2017 | 654 | 1.830 |
Why?
|
| Uterine Neoplasms | 8 | 2018 | 1420 | 1.800 |
Why?
|
| Ovulation Induction | 5 | 2017 | 277 | 1.390 |
Why?
|
| Live Birth | 9 | 2022 | 511 | 1.040 |
Why?
|
| Oocyte Donation | 2 | 2016 | 52 | 1.010 |
Why?
|
| Oocytes | 4 | 2018 | 1166 | 0.990 |
Why?
|
| Infertility, Female | 11 | 2022 | 760 | 0.940 |
Why?
|
| Pregnancy Rate | 11 | 2019 | 648 | 0.850 |
Why?
|
| Myometrium | 4 | 2018 | 174 | 0.820 |
Why?
|
| Anti-Mullerian Hormone | 4 | 2022 | 407 | 0.770 |
Why?
|
| MicroRNAs | 5 | 2018 | 3816 | 0.740 |
Why?
|
| Ovarian Follicle | 4 | 2022 | 244 | 0.720 |
Why?
|
| Ovary | 5 | 2022 | 959 | 0.710 |
Why?
|
| Embryo Transfer | 7 | 2016 | 522 | 0.670 |
Why?
|
| Insemination, Artificial | 2 | 2017 | 99 | 0.660 |
Why?
|
| Estradiol | 6 | 2015 | 1937 | 0.620 |
Why?
|
| Oocyte Retrieval | 6 | 2019 | 160 | 0.600 |
Why?
|
| Fertilization | 1 | 2018 | 199 | 0.590 |
Why?
|
| Fertility Agents | 1 | 2017 | 11 | 0.570 |
Why?
|
| Ovulation | 2 | 2018 | 181 | 0.560 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.550 |
Why?
|
| Pregnancy Outcome | 10 | 2016 | 2921 | 0.540 |
Why?
|
| Single Embryo Transfer | 1 | 2016 | 29 | 0.530 |
Why?
|
| Fallopian Tube Diseases | 1 | 2016 | 60 | 0.510 |
Why?
|
| Endometriosis | 3 | 2014 | 870 | 0.480 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 469 | 0.480 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 137 | 0.470 |
Why?
|
| Spermatozoa | 1 | 2018 | 630 | 0.470 |
Why?
|
| Pre-Eclampsia | 4 | 2022 | 1231 | 0.460 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2023 | 376 | 0.420 |
Why?
|
| Cryopreservation | 5 | 2016 | 728 | 0.410 |
Why?
|
| Thyrotropin | 1 | 2016 | 834 | 0.400 |
Why?
|
| Abscess | 1 | 2016 | 606 | 0.400 |
Why?
|
| Pregnancy | 24 | 2022 | 29874 | 0.390 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 750 | 0.370 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1726 | 0.350 |
Why?
|
| Postmenopause | 2 | 2011 | 2513 | 0.350 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2017 | 1208 | 0.350 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2012 | 461 | 0.350 |
Why?
|
| Professional Practice | 1 | 2010 | 313 | 0.310 |
Why?
|
| Twinning, Monozygotic | 1 | 2007 | 17 | 0.290 |
Why?
|
| Waist Circumference | 1 | 2011 | 935 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8547 | 0.260 |
Why?
|
| Twins | 1 | 2007 | 339 | 0.260 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2005 | 69 | 0.250 |
Why?
|
| Female | 51 | 2023 | 392644 | 0.250 |
Why?
|
| Adipokines | 1 | 2007 | 310 | 0.250 |
Why?
|
| Leptin | 3 | 2007 | 1597 | 0.240 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 1390 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1809 | 0.230 |
Why?
|
| Physical Fitness | 1 | 2008 | 743 | 0.230 |
Why?
|
| Walking | 1 | 2011 | 1198 | 0.230 |
Why?
|
| Embryo Disposition | 1 | 2003 | 14 | 0.220 |
Why?
|
| Preservation, Biological | 1 | 2003 | 26 | 0.220 |
Why?
|
| Tissue Donors | 2 | 2003 | 2331 | 0.220 |
Why?
|
| Chorionic Villi | 1 | 2003 | 53 | 0.220 |
Why?
|
| Semen Preservation | 1 | 2003 | 35 | 0.220 |
Why?
|
| Fertility | 3 | 2017 | 771 | 0.210 |
Why?
|
| Embryo Implantation | 2 | 2016 | 270 | 0.210 |
Why?
|
| Cell Count | 4 | 2017 | 1835 | 0.210 |
Why?
|
| Body Mass Index | 2 | 2019 | 12953 | 0.200 |
Why?
|
| Body Composition | 1 | 2011 | 2426 | 0.190 |
Why?
|
| Adult | 30 | 2023 | 221177 | 0.190 |
Why?
|
| Adnexal Diseases | 1 | 2002 | 104 | 0.190 |
Why?
|
| Menopause | 1 | 2008 | 1646 | 0.180 |
Why?
|
| Body Weight | 1 | 2011 | 4618 | 0.180 |
Why?
|
| Chorionic Gonadotropin | 2 | 2012 | 457 | 0.170 |
Why?
|
| Acromegaly | 1 | 2023 | 310 | 0.170 |
Why?
|
| Premature Birth | 1 | 2012 | 1782 | 0.170 |
Why?
|
| Weight Loss | 1 | 2011 | 2684 | 0.170 |
Why?
|
| Humans | 49 | 2023 | 761504 | 0.170 |
Why?
|
| Cytokines | 1 | 2014 | 7396 | 0.160 |
Why?
|
| Hysterosalpingography | 1 | 2018 | 26 | 0.160 |
Why?
|
| Ultrasonography | 3 | 2022 | 5972 | 0.160 |
Why?
|
| Mediator Complex | 2 | 2015 | 106 | 0.150 |
Why?
|
| Birth Rate | 1 | 2019 | 168 | 0.150 |
Why?
|
| Vitrification | 2 | 2016 | 51 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2018 | 156 | 0.150 |
Why?
|
| Sperm Count | 1 | 2018 | 229 | 0.150 |
Why?
|
| Posthumous Conception | 2 | 2010 | 11 | 0.150 |
Why?
|
| Matched-Pair Analysis | 1 | 2018 | 284 | 0.150 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1675 | 0.140 |
Why?
|
| Uterus | 2 | 2014 | 649 | 0.140 |
Why?
|
| Sperm Motility | 1 | 2018 | 266 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7407 | 0.140 |
Why?
|
| Parity | 2 | 2022 | 927 | 0.140 |
Why?
|
| Climacteric | 1 | 2017 | 57 | 0.140 |
Why?
|
| Pregnancy Tests | 1 | 2017 | 33 | 0.140 |
Why?
|
| Semen Analysis | 1 | 2018 | 236 | 0.140 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2016 | 34 | 0.130 |
Why?
|
| Obesity | 3 | 2019 | 12947 | 0.130 |
Why?
|
| Menstrual Cycle | 2 | 2016 | 539 | 0.130 |
Why?
|
| Estrogens | 3 | 2017 | 1522 | 0.120 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2014 | 36 | 0.120 |
Why?
|
| Oogenesis | 1 | 2014 | 124 | 0.110 |
Why?
|
| Prevalence | 3 | 2017 | 15732 | 0.110 |
Why?
|
| Syringes | 1 | 2013 | 58 | 0.110 |
Why?
|
| Mullerian Ducts | 1 | 2014 | 203 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2016 | 9646 | 0.110 |
Why?
|
| Cell Line | 2 | 2018 | 15601 | 0.110 |
Why?
|
| Maternal Age | 1 | 2016 | 809 | 0.110 |
Why?
|
| Treatment Outcome | 10 | 2017 | 64680 | 0.100 |
Why?
|
| Menarche | 1 | 2015 | 532 | 0.100 |
Why?
|
| Infertility, Male | 1 | 2016 | 395 | 0.100 |
Why?
|
| Retrospective Studies | 13 | 2023 | 80636 | 0.100 |
Why?
|
| Placenta | 1 | 2022 | 1709 | 0.100 |
Why?
|
| Reproductive Control Agents | 1 | 2012 | 6 | 0.100 |
Why?
|
| Pregnancy, Ectopic | 1 | 2013 | 142 | 0.100 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2012 | 47 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2014 | 2448 | 0.100 |
Why?
|
| Aging | 2 | 2008 | 8708 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 533 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 597 | 0.100 |
Why?
|
| Insurance Coverage | 2 | 2016 | 1940 | 0.100 |
Why?
|
| Age Distribution | 1 | 2017 | 2880 | 0.090 |
Why?
|
| Young Adult | 8 | 2022 | 59243 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 1250 | 0.090 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 29 | 0.090 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 412 | 0.090 |
Why?
|
| Logistic Models | 2 | 2016 | 13255 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 9539 | 0.090 |
Why?
|
| Third-Party Consent | 1 | 2010 | 66 | 0.090 |
Why?
|
| Risk Factors | 6 | 2022 | 74206 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 3492 | 0.080 |
Why?
|
| Placenta Diseases | 1 | 2012 | 199 | 0.080 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 138 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2016 | 2645 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 21012 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3416 | 0.080 |
Why?
|
| Boston | 1 | 2022 | 9326 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6132 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2013 | 721 | 0.080 |
Why?
|
| Reproduction | 2 | 2023 | 645 | 0.080 |
Why?
|
| Breast | 1 | 2017 | 1967 | 0.070 |
Why?
|
| Birth Weight | 1 | 2016 | 2103 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 2803 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2007 | 23445 | 0.070 |
Why?
|
| Diet | 2 | 2015 | 8075 | 0.070 |
Why?
|
| Resistin | 1 | 2007 | 172 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2014 | 1819 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6310 | 0.070 |
Why?
|
| Estrone | 1 | 2007 | 234 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2022 | 26198 | 0.070 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 378 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2014 | 22169 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2022 | 54425 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 124 | 0.060 |
Why?
|
| Adolescent | 6 | 2019 | 88319 | 0.060 |
Why?
|
| Cyclins | 1 | 2007 | 594 | 0.060 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 726 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
| Prognosis | 3 | 2017 | 29625 | 0.060 |
Why?
|
| Fertility Agents, Female | 1 | 2005 | 101 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2008 | 624 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8830 | 0.060 |
Why?
|
| Life Style | 1 | 2015 | 3917 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 18252 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2007 | 655 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2498 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 546 | 0.050 |
Why?
|
| Leuprolide | 1 | 2005 | 312 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2016 | 7967 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2012 | 2025 | 0.050 |
Why?
|
| Premenopause | 1 | 2007 | 1039 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2747 | 0.050 |
Why?
|
| Mice | 8 | 2015 | 81525 | 0.050 |
Why?
|
| Tissue Banks | 1 | 2003 | 184 | 0.050 |
Why?
|
| Adnexa Uteri | 1 | 2002 | 40 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 15266 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10445 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2065 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3688 | 0.050 |
Why?
|
| Marital Status | 1 | 2003 | 426 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12059 | 0.050 |
Why?
|
| Torsion Abnormality | 1 | 2002 | 91 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2015 | 4398 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4758 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 1496 | 0.040 |
Why?
|
| Inflammation | 2 | 2014 | 10773 | 0.040 |
Why?
|
| United States | 3 | 2017 | 72334 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4481 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5769 | 0.040 |
Why?
|
| Middle Aged | 5 | 2019 | 220895 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2007 | 2932 | 0.040 |
Why?
|
| Death | 1 | 2003 | 676 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2023 | 463 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1496 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 177 | 0.040 |
Why?
|
| Women's Health | 1 | 2007 | 2065 | 0.040 |
Why?
|
| Animals | 8 | 2015 | 168459 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2645 | 0.040 |
Why?
|
| Arteries | 1 | 2002 | 1123 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 2822 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10194 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 39967 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2009 | 3242 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2078 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4352 | 0.030 |
Why?
|
| Male | 7 | 2018 | 360804 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2022 | 22176 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 2057 | 0.030 |
Why?
|
| Quality of Life | 2 | 2014 | 13367 | 0.030 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2014 | 44 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2007 | 4936 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2015 | 1310 | 0.030 |
Why?
|
| Motivation | 1 | 2003 | 2006 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10766 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2008 | 4792 | 0.030 |
Why?
|
| Suction | 1 | 2013 | 266 | 0.030 |
Why?
|
| Meiosis | 1 | 2014 | 328 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17904 | 0.020 |
Why?
|
| Blastocyst | 1 | 2014 | 433 | 0.020 |
Why?
|
| Mesoderm | 1 | 2014 | 674 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2014 | 1152 | 0.020 |
Why?
|
| Progesterone | 1 | 2015 | 742 | 0.020 |
Why?
|
| Ethics Committees, Clinical | 1 | 2010 | 56 | 0.020 |
Why?
|
| beta Catenin | 1 | 2015 | 1040 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2015 | 857 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 16591 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1560 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 193 | 0.020 |
Why?
|
| Sirolimus | 1 | 2014 | 1533 | 0.020 |
Why?
|
| Fibrosis | 1 | 2014 | 2049 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5073 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 2665 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2018 | 2035 | 0.020 |
Why?
|
| Ovum | 1 | 2007 | 187 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 617 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 350 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2006 | 451 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2629 | 0.010 |
Why?
|
| Germ Cells | 1 | 2007 | 634 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 169289 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1927 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1699 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8631 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2013 | 41487 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2010 | 1514 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 6965 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 23742 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6216 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3429 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2567 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 5492 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11903 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 4358 | 0.010 |
Why?
|
| Child | 1 | 2002 | 80153 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39106 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14414 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 30052 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18395 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16981 | 0.010 |
Why?
|
Concepts
(255)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_